MLchartDataset catalogue

DT388IL3 fusion protein

Term · Oncology and biomedicine · MLC-T-ONC-002600

A substance being studied in the treatment of myeloid leukemia (a disease in which too many immature non-lymphocyte white blood cells are found in the blood and bone marrow). DT388IL3 fusion protein is made by combining IL-3 with a toxic substance. The IL-3 attaches to the cancer cells and the toxic substance kills them.

Table 1. Record
IdentifierMLC-T-ONC-002600
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-002600",
  "term": "DT388IL3 fusion protein",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of myeloid leukemia (a disease in which too many immature non-lymphocyte white blood cells are found in the blood and bone marrow). DT388IL3 fusion protein is made by combining IL-3 with a toxic substance. The IL-3 attaches to the cancer cells and the toxic substance kills them.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/dt388il3-fusion-protein/"
}

Record 6,263 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.